• The 70-gene Prognosis-Signature Predicts Disease Outcome in Breast Cancer Patients with 1-3 Positive Lymph Nodes in an Independent Validation Study

  The 70-gene Prognosis-Signature Predicts Disease Outcome in Breast Cancer Patients with 1-3 Positive Lymph Nodes in an Independent Validation Study

  Evidence, MammaPrint, Other, Validation

The 70-gene Prognosis-Signature Predicts Disease Outcome in Breast Cancer Patients with 1-3 Positive Lymph Nodes in an Independent Validation Study

PUBLICATION: Breast Cancer Res Treat. 2009 Jul;116(2):295-302. doi: 10.1007/s10549-008-0130-2. Epub Read More

kevin2024-03-25T11:09:15-04:00July 27th, 2009|Evidence, MammaPrint, Other, Validation|

Read More

• Daily Clinical Practice of Fresh Tumour Tissue Freezing and Gene Expression Profiling; Logistics Pilot Study Preceding the MINDACT Trial

  Daily Clinical Practice of Fresh Tumour Tissue Freezing and Gene Expression Profiling; Logistics Pilot Study Preceding the MINDACT Trial

  Evidence, MammaPrint, Other

Daily Clinical Practice of Fresh Tumour Tissue Freezing and Gene Expression Profiling; Logistics Pilot Study Preceding the MINDACT Trial

PUBLICATION: Eur J Cancer. 2009 May;45(7):1201-1208. doi: 10.1016/j.ejca.2009.01.004. Epub 2009 Read More

kevin2024-03-25T11:09:51-04:00May 1st, 2009|Evidence, MammaPrint, Other|

Read More

• 

  Constructive Technology Assessment (CTA) as a Tool in Coverage with Evidence Development: The Case of the 70-gene Prognosis Signature for Breast Cancer Diagnostics

  Gallery

  Constructive Technology Assessment (CTA) as a Tool in Coverage with Evidence Development: The Case of the 70-gene Prognosis Signature for Breast Cancer Diagnostics

  Evidence, MammaPrint, Other

Constructive Technology Assessment (CTA) as a Tool in Coverage with Evidence Development: The Case of the 70-gene Prognosis Signature for Breast Cancer Diagnostics

PUBLICATION: Int J Technol Assess Health Care. 2009 Jan;25(1):73-83. doi: Read More

kevin2024-03-25T11:11:06-04:00January 24th, 2009|Evidence, MammaPrint, Other|

Read More

• Robust Interlaboratory Reproducibility of a Gene Expression Signature Measurement Consistent with the Needs of a New Generation of Diagnostic Tools

  Robust Interlaboratory Reproducibility of a Gene Expression Signature Measurement Consistent with the Needs of a New Generation of Diagnostic Tools

  Evidence, MammaPrint, Other, Validation

Robust Interlaboratory Reproducibility of a Gene Expression Signature Measurement Consistent with the Needs of a New Generation of Diagnostic Tools

PUBLICATION: BMC Genomics. 2007 Jun 7;8:148. AUTHORS: Ach R.A., Floore Read More

kevin2024-03-25T11:15:05-04:00June 7th, 2007|Evidence, MammaPrint, Other, Validation|

Read More

• 

  Converting a Breast Cancer Microarray Signature into a High-Throughput Diagnostic Test

  Gallery

  Converting a Breast Cancer Microarray Signature into a High-Throughput Diagnostic Test

  Evidence, MammaPrint, Other, Validation

Converting a Breast Cancer Microarray Signature into a High-Throughput Diagnostic Test

PUBLICATION: BMC Genomics. 2006 Oct 30;7:278. AUTHORS:  Glas A.M., Floore Read More

kevin2024-03-25T11:16:18-04:00October 30th, 2006|Evidence, MammaPrint, Other, Validation|

Read More

• Gene Expression Profiles of Primary Breast Carcinomas from Patients at High-Risk for Local Recurrence After Breast-Conserving Therapy

  Gene Expression Profiles of Primary Breast Carcinomas from Patients at High-Risk for Local Recurrence After Breast-Conserving Therapy

  Evidence, MammaPrint, Other

Gene Expression Profiles of Primary Breast Carcinomas from Patients at High-Risk for Local Recurrence After Breast-Conserving Therapy

PUBLICATION: Clin Cancer Res. 2006 Oct 1;12(19):5705-12. AUTHORS: Kreike B., Read More

kevin2024-03-25T11:17:36-04:00October 1st, 2006|Evidence, MammaPrint, Other|

Read More

• Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women with Node-Negative Breast Cancer

  Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women with Node-Negative Breast Cancer

  Evidence, MammaPrint, Other, Validation

Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women with Node-Negative Breast Cancer

PUBLICATION: J Natl Cancer Inst. 2006 Sep 6;98(17):1183-92. AUTHORS: Buyse Read More

kevin2024-03-25T11:18:22-04:00September 6th, 2006|Evidence, MammaPrint, Other, Validation|

Read More

• Molecular Portraits and 70-gene Prognosis Signature Are Preserved Throughout the Metastatic Process of Breast Cancer

  Molecular Portraits and 70-gene Prognosis Signature Are Preserved Throughout the Metastatic Process of Breast Cancer

  Evidence, MammaPrint, Other, Validation

Molecular Portraits and 70-gene Prognosis Signature Are Preserved Throughout the Metastatic Process of Breast Cancer

PUBLICATION: Cancer Res. 2005 Oct 15;65(20):9155-8. AUTHORS: Weigelt B., Hu Read More

kevin2024-03-25T11:19:17-04:00October 5th, 2005|Evidence, MammaPrint, Other, Validation|

Read More

• Gene Expression Profiling of Breast Cancer: A New Tumor Marker

  Gene Expression Profiling of Breast Cancer: A New Tumor Marker

  Evidence, MammaPrint, Other, Validation

Gene Expression Profiling of Breast Cancer: A New Tumor Marker

PUBLICATION: Journal of Clinical Oncology March 10, 2005 23:8, 1631-1635 Read More

kevin2024-03-25T11:19:45-04:00March 10th, 2005|Evidence, MammaPrint, Other, Validation|

Read More

• A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

  Evidence, MammaPrint, Other, Validation

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

PUBLICATION: N Engl J Med. 2002 Dec 19;347(25):1999-2009. AUTHORS: van Read More

kevin2024-03-07T11:00:44-05:00December 19th, 2002|Evidence, MammaPrint, Other, Validation|

Read More